中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

13 records (took 0.013 seconds)

    MEMORIES AND METHODS FOR SHARING A SIGNAL NODE FOR THE RECEIPT AND PROVISION OF NON-DATA SIGNALS
    1.
    发明申请
    MEMORIES AND METHODS FOR SHARING A SIGNAL NODE FOR THE RECEIPT AND PROVISION OF NON-DATA SIGNALS 审中-公开
    用于共享用于接收和提供非数据信号的信号节点的记忆和方法

    公开(公告)号：WO2012030497A1

    公开(公告)日：2012-03-08

    申请号：PCT/US2011/047430

    申请日：2011-08-11

    Applicant: MICRON TECHNOLOGY INC. ,  HUBER, Brian

    Inventor： HUBER, Brian

    IPC: G11C7/22 ,  G11C7/10

    CPC classification number: G11C8/18 ,  G11C7/10 ,  G11C7/1084

    Abstract: Memories and methods for providing and receiving non-data signals at a signal node are disclosed. One such memory includes first and second signal nodes, and first and second signal buffer. The first signal buffer is configured to be operative responsive to a first data strobe signal and further configured to be operative responsive to a non-data signal. The second signal buffer is configured to be operative responsive to a second data strobe signal. An example first data strobe signal is a read data strobe signal provided by the memory. In another example, the first data strobe signal is a write data strobe signal received by the memory. Examples of non-data signals include a data mask signal, data valid signal, error correction signal, as well as other signals.

    Abstract translation: 公开了在信号节点处提供和接收非数据信号的存储器和方法。 一个这样的存储器包括第一和第二信号节点以及第一和第二信号缓冲器。 第一信号缓冲器被配置为响应于第一数据选通信号而工作，并且还被配置为响应于非数据信号而工作。 第二信号缓冲器被配置为响应于第二数据选通信号而工作。 示例性的第一数据选通信号是由存储器提供的读数据选通信号。 在另一示例中，第一数据选通信号是由存储器接收的写数据选通信号。 非数据信号的示例包括数据屏蔽信号，数据有效信号，纠错信号以及其它信号。

    CHIMERIC TAR ENZYME CONSTRUCTION FOR HIV THERAPY
    7.
    发明申请
    CHIMERIC TAR ENZYME CONSTRUCTION FOR HIV THERAPY 审中-公开
    用于艾滋病毒治疗的CHIMERIC TAR ENZYME施工

    公开(公告)号：WO1992015693A1

    公开(公告)日：1992-09-17

    申请号：PCT/GB1992000341

    申请日：1992-02-26

    Applicant: THE WELLCOME FOUNDATION LIMITED ,  HUBER, Brian ,  RICHARDS, Cynthia, Ann ,  MARTIN, Jean, Louise

    Inventor： THE WELLCOME FOUNDATION LIMITED

    IPC: C12N15/85

    CPC classification number: C07K14/005 ,  A61K38/00 ,  A61K48/00 ,  C12N9/1211 ,  C12N2740/16322

    Abstract: The present invention relates to molecular chimaeras, infective virions, to methods of their construction, to pharmaceutical formulations containing them, to their use in therapy, particularly virus-directed enzyme prodrug therapy particularly in the treatment of HIV, and to the use of agents which can be catalysed by a heterologous enzyme to cytotoxic or cytostatic metabolites, such as purine arabinosides and substituted pyrimidines in virus-directed enzyme prodrug therapy, in a mammalian host (e.g. human).

    Abstract translation: 本发明涉及分子嵌合体，感染性病毒体，其构建方法，含有它们的药物制剂，其在治疗中的用途，特别是病毒导向的酶前药治疗，特别是用于治疗HIV，以及使用 可以通过异源酶在哺乳动物宿主（例如人）中通过病毒定向的酶前药治疗中的细胞毒性或细胞抑制代谢物例如嘌呤阿糖苷和取代的嘧啶来催化。

Patent Agency Ranking